Latest news
Latest news
Resets for 2021 and 2024 deals are less attractive to managers due to wider liability pricing
Spreads for the triple-A rated notes were similar to the manager's previous deal
State of New Hampshire's innovative bond gets Ba2 rating
More articles
More articles
-
Last week marked what looks like the death of the Trans-Pacific Partnership (TPP), a comprehensive trade agreement that would have heralded closer integration between the US and the high growth economies of the Asia-Pacific region. -
US CLO market players have quickly moved past the shock result of last week’s presidential election, refocusing on the US risk retention deadline on December 24.
-
European ABS spreads widened briefly on Wednesday morning after the shock US election result, but quickly recovered.
-
US private equity firm Och-Ziff Capital Management closed its first European CLO on Thursday, as pricing of junior CLO debt defies the tightening seen at the top of the capital stack.
-
Valeant Pharmaceuticals, the biggest obligor in US CLOs, is understood to be selling off assets in an attempt to pay down debt. But it may not be the shot in the arm the sector is after, writes Sam Kerr.
-
With aggressive leveraged loan repricing hitting the returns to CLO structures, managers are taking a variety of steps to protect their portfolios.
-
Derivatives and fixed income valuation and risk analytics provider FINCAD has added securitization to its coverage.
-
With Europe’s leveraged loan market undergoing a “repricing frenzy”, CLO managers are looking to refinance deals coming out of non-call periods over the next few months in order to protect equity returns in those deals.
-
The US new issue CLO market finished last week with a flurry of deals.
